Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Get Free Report) traded down 5.2% during trading on Monday . The stock traded as low as $14.15 and last traded at $14.0360. 872,483 shares traded hands during trading, a decline of 57% from the average session volume of 2,043,963 shares. The stock had previously closed at $14.81. Analyst Ratings […]

Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Get Free Report) COO Julie Rubinstein sold 19,060 shares of the stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $14.45, for a total value of $275,417.00. Following the transaction, the chief operating officer owned 451,540 shares in the company, valued at […]